CD27/CD70 and idiopathic pulmonary fibrosis

doi:10.16352/j.issn.1001-6325.2024.08.1170

Abstract

Abstract: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease marked by the significant involvement of fibroblasts, macrophages and lymphocytes. The CD27/CD70 axis is pivotal in shaping the immune microenvironment present in the fibrotic aeras of lungs. This mentioned interaction involves molecular pathways that work in tandem with lung immune cells, particularly exerting a suppressive influence in the early phases of pulmonary fibrosis. Consequently, the CD27/CD70 axis presents a promising new target for immunotherapy in IPF.

Key words: idiopathic pulmonary fibrosis, CD27/CD70 axis, PI3K/AKT pathway

CLC Number:

R563.9

XU Yuncong, ZHENG Jinxu. CD27/CD70 and idiopathic pulmonary fibrosis[J]. Basic & Clinical Medicine, 2024, 44(8): 1170-1174.

References

[1] Cottin V, Martinez FJ, Jenkins RG, et al. Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial[J]. Respir Res, 2022, 23: 85.doi:10.1186/s12931-022-01974-2.
[2] Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis[J]. Annu Rev Pathol, 2022, 17: 515-546.doi:10.1146/annurev-pathol-042320-030240.
[3] Yao C, Guan X, Carraro G, et al. Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2021, 203: 707-717.doi:10.1164/rccm.202004-1274OC.
[4] Löfdahl A, Nybom A, Wigén J, et al. Pulmonary 5-HT(2B) receptor expression in fibrotic interstitial lung diseases[J]. Acta Histochem, 2023, 125: 152024.doi:10.1016/j.acthis.2023.152024.
[5] Lebel M, Cliche DO, Charbonneau M, et al. Invadosome formation by lung fibroblasts in idiopathic pulmonary fibrosis[J]. Int J Mol Sci, 2022, 24.doi:10.3390/ijms24010499.
[6] Richter J, Oschlies I, Kock K, et al. CD27/CD70 pathway activation in primary cutaneous CD4⁺ small/medium T-cell lymphoproliferative disorder[J]. J Pathol, 2024, 262: 189-197.doi:10.1002/path.6222.
[7] Jaeger-Ruckstuhl CA, Lo Y, Fulton E, et al. Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks[J]. Immunity, 2024, 57: 287-302.doi:10.1016/j.immuni.2024.01.011.
[8] Cagnet L, Neyrinck-Leglantier D, Tamagne M, et al. CD27(+) microparticle interactions and immunoregulation of CD4(+) T lymphocytes[J]. Front Immunol, 2023, 14: 1043255.doi:10.3389/fimmu.2023.1043255.
[9] Bowakim-Anta N, Acolty V, Azouz A, et al. Chronic CD27-CD70 costimulation promotes type 1-specific polarization of effector Tregs[J]. Front Immunol, 2023, 14: 1023064.doi:10.3389/fimmu.2023.1023064.
[10] Serezani APM, Pascoalino BD, Bazzano JMR, et al. Multiplatform single-cell analysis identifies immune cell types enhanced in pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2022, 67: 50-60.doi:10.1165/rcmb.2021-0418OC.
[11] Liu YZ, Saito S, Morris GF, et al. Proportions of resting memory T cells and monocytes in blood have prognostic significance in idiopathic pulmonary fibrosis[J]. Genomics, 2019, 111: 1343-1350.doi:10.1016/j.ygeno.2018.09.006.
[12] Inui N, Sakai S, Kitagawa M. Molecular pathogenesis of pulmonary fibrosis, with focus on pathways related to TGF-β and the ubiquitin-proteasome pathway[J]. Int J Mol Sci, 2021, 22.doi:10.3390/ijms22116107.
[13] Tran-Nguyen TK, Xue J, Feghali-Bostwick C, et al. CD70 activation decreases pulmonary fibroblast production of extracellular matrix proteins[J]. Am J Respir Cell Mol Biol, 2020, 63: 255-265.doi:10.1165/rcmb.2019-0450OC.
[14] Wasiuk A, Weidlick J, Sisson C, et al. Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice[J]. Cancer Immunol Immunother, 2022, 71: 97-109.doi:10.1007/s00262-021-02958-9.
[15] Allard-Chamard H, Kaneko N, Bertocchi A, et al. Extrafollicular IgD(-)CD27(-)CXCR5(-)CD11c(-) DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19[J]. Cell Rep, 2023, 42: 112630.doi:10.1016/j.celrep.2023.112630.
[16] van Gisbergen KP, van Olffen RW, van Beek J, et al. Protective CD8 T cell memory is impaired during chronic CD70-driven costimulation[J]. J Immunol, 2009, 182: 5352-5362.doi:10.4049/jimmunol.0802809.
[17] Janho Dit Hreich S, Juhel T, Leroy S, et al. Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis[J]. Elife, 2024, 12.doi:10.7554/eLife.88138.
[18] Hult EM, Gurczynski SJ, Moore BB. M2 macrophages have unique transcriptomes but conditioned media does not promote profibrotic responses in lung fibroblasts or alveolar epithelial cells in vitro[J]. Am J Physiol Lung Cell Mol Physiol, 2021, 321: l518-l532.doi:10.1152/ajplung.00107.2021.
[19] Yang P, Luo Q, Wang X, et al. Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases[J]. Am J Respir Crit Care Med, 2023, 207: 160-172.doi:10.1164/rccm.202110-2414OC.
[20] Nascimento Júnior JXD, Sola-Penna M, Zancan P. Clotrimazole reverses macrophage M2 polarization by disrupt-ing the PI3K/AKT/mTOR pathway[J]. Biochem Biophys Res Commun, 2023, 696: 149455.doi:10.1016/j.bbrc.2023.149455.
[21] Wu Y, Zhang J, Wang X, et al. Saikosaponin-d regulates angiogenesis in idiopathic pulmonary fibrosis through angiopoietin/Tie-2 pathway[J]. Acta Histochem, 2023, 125: 152100.doi:10.1016/j.acthis.2023.152100.
[22] Pandey AK, Waldeck-Weiermair M, Wells QS, et al. Expression of CD70 modulates nitric oxide and redox status in endothelial cells[J]. Arterioscler Thromb Vasc Biol, 2022, 42: 1169-1185.doi:10.1161/atvbaha.122.317866.
[23] Xu Z, Davies ER, Yao L, et al. LKB1 depletion-mediated epithelial-mesenchymal transition induces fibroblast activation in lung fibrosis[J]. Genes Dis, 2024, 11: 101065.doi:10.1016/j.gendis.2023.06.034.
[24] Ortiz-Cuaran S, Swalduz A, Foy JP, et al. Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer[J]. Eur J Cancer, 2022, 169: 106-122.doi:10.1016/j.ejca.2022.03.038.
[25] Thillai M, Oldham JM, Ruggiero A, et al. Deep learning-based segmentation of CT scans predicts disease progression and mortality in IPF[J]. Am J Respir Crit Care Med, 2024.doi:10.1164/rccm.202311-2185OC.